Vice President Clinical Development
GRAIL
Vice President Clinical Development
GRAIL
Blood-based cancer detection via sequencing tests
The Vice President, Clinical Development provides enterprise leadership in defining and executing GRAIL’s clinical development strategy and operations. This role defines the vision, direction, and executional framework for all clinical programs, ensuring alignment with corporate objectives and scientific priorities. The position oversees the governance and delivery of clinical studies across all phases, guiding strategic decisions that support regulatory success and product advancement.
This role drives organizational excellence, cultivates talent, and represents Clinical Development in enterprise, regulatory, and external partnership settings in collaboration with relevant functions.
This role is based in Sunnyvale, California, and the majority of your work will be performed there. We currently offer a flexible work arrangement that requires that at least 60% (24 hours) of your total workweek be on-site. Your specific schedule, determined in collaboration with your manager, will align with team and business needs and could require up to 5 days per week in the office. At our Sunnyvale site, Tuesdays and Thursdays are the key days when we encourage on-site presence to foster greater collaboration, faster decision-making, and engagement in events and on-site activities.
These job duties are a summary of the primary duties and responsibilities of the job and position. It is not intended to be a comprehensive or all-inclusive listing of duties and responsibilities. Contents are subject to change at the company's discretion.
Essential Skills
Frequent domestic and international travel required for governance meetings, regulatory interactions, and strategic partnership engagements.
At GRAIL, we believe in recognizing and rewarding the contributions our employees make to our mission and success. In addition to base pay, this role may be eligible for additional compensation, including an annual bonus and/or other incentives, in accordance with applicable plans and the company's discretion. The posted range reflects our good-faith estimate of the base pay we expect to offer for this position at the time of hire. Actual compensation will be determined based on factors such as the candidate’s experience, skills, qualifications, and other relevant considerations.
At GRAIL, we invest in the health, well-being, and future of our employees and their families. Employees in this role are eligible for a comprehensive and competitive benefits package designed to support what matters most, including flexible time off or vacation, a 401(k) retirement plan with employer match, medical, dental, and vision coverage, and thoughtfully selected well-being programs. Benefits are offered in accordance with applicable plans and policies.
GRAIL is an equal employment opportunity employer, and we are committed to building a workplace where every individual can thrive, contribute, and grow. All qualified applicants will receive consideration for employment without regard to race, color, religion, national origin, sex, gender, gender identity, sexual orientation, age, disability, status as a protected veteran, or any other class or characteristic protected by applicable federal, state, and local laws. Additionally, GRAIL will consider for employment qualified applicants with arrest and conviction records in a manner consistent with applicable law and provide reasonable accommodations to qualified individuals with disabilities. Please contact us at [email protected] if you require an accommodation to apply for an open position.
GRAIL maintains a drug-free workplace. We welcome job-seekers from all backgrounds to join us!
Pursuant to the San Francisco Fair Chance Ordinance, we will consider for employment qualified applicants with arrest and conviction records.
GRAIL develops blood-based cancer tests that aim to detect cancer at its earliest stages. The tests use high-intensity sequencing to analyze large amounts of tumor genome data from a blood sample and apply advanced algorithms and deep learning to identify signals indicating cancer. Revenue comes from selling these tests to healthcare providers and research institutions, with potential expansion to direct-to-consumer sales in the future. Compared with others, GRAIL combines extensive sequencing data with clinical studies and sophisticated analytics to provide actionable cancer-detection results, focusing on early diagnosis. The company’s goal is to lower global cancer mortality by catching the disease early when treatment is more effective.
Explore more opportunities at GRAIL